On October 29, nearly 200 members of the local, national, and international digital health community—including researchers, clinicians, healthcare administrators, payors, investors, experts from government and industry, and students and trainees—gathered for a daylong meeting at Dartmouth College to discuss the expanding field of digital therapeutics.
The Center for Technology and Behavioral Health (CTBH) at the Geisel School of Medicine at Dartmouth has announced an innovative collaboration with Boehringer Ingelheim with the goal of advancing prescription digital therapeutics that specifically target serious mental illness.
A new Dartmouth-led study, published in the journal BMC Public Health, shows that even small effects from environmental exposures to toxins like air pollution, PFAS (forever chemicals), and arsenic in well water can adversely affect the health of vulnerable groups like mothers and their babies.
Two teams of researchers at Dartmouth’s Geisel School of Medicine and Thayer School of Engineering, led by David Leib, PhD, and Margaret Ackerman, PhD, will be among the recipients of grant funding from the federal Advanced Research Program for Health (ARPA-H) to support innovations in pandemic preparedness and vaccine generation.
On Wednesday, September 18, Geisel School of Medicine and Dartmouth Health (DH) celebrated their first-ever Biomedical Research Day. The landmark event, held at Dartmouth Hitchcock Medical Center (DHMC), was a celebration of the breadth and impact of the institution’s research enterprise and was marked by strong attendance with well over 260 faculty and trainees taking part.
Dartmouth Health’s Dartmouth Hitchcock Medical Center received a $27.7 million, seven-year grant from the National Institutes of Health (NIH) to fund projects that will speed the implementation of proven medical innovations as part of a national consortium of biomedical research centers.
Since joining Dartmouth in 2021, Charles Thomas, Jr., MD, has played a pivotal role in transforming the Radiation Oncology section into a full department, now serving as its founding chair. In this Q&A, Dr. Thomas reflects on his longstanding connection to Dartmouth, the dynamic changes within the field of radiation oncology, and outlines his vision for the department’s future.
Dartmouth recently earned national recognition as a Skin Smart Campus from the National Council on Skin Cancer Prevention, thanks to the efforts of Jamie Karch, who earned her MD degree from Geisel in May, and many collaborators across Dartmouth and the broader Upper Valley community.
Results from a new Dartmouth-led study, involving collaborators at the University of Pittsburgh and Yale University and published in the journal PLOS Biology, are providing new insights into the therapeutic potential of bacteriophage (phage) therapy for treating diseases like cystic fibrosis (CF).
Findings from a new study, led by researchers at Dartmouth’s Geisel School of Medicine and published in Nature Immunology, have uncovered key functional differences in macrophages—a type of white blood cell that plays a pivotal role in the body’s innate (general) immune system as a first-line defender against pathogens.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.